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Abstract. 
 
Cells can vary their adhesive properties by 
modulating the affinity of integrin receptors. The acti-
vation and inactivation of integrins by inside-out mech-
anisms acting on the cytoplasmic domains of the inte-
grin subunits has been demonstrated in platelets, 
lymphocytes, and keratinocytes. We show that in the 
embryo, normal morphogenesis requires the 
 
a
 
 subunit 
cytoplasmic domain to control integrin adhesion at the 
right times and places. PS2 integrin (
 
a
 
PS2
 
b
 
PS
 
) adhesion 
is normally restricted to the muscle termini, where it is 
required for attaching the muscles to the ends of other 
muscles and to specialized epidermal cells. Replacing 
the wild-type 
 
a
 
PS2
 
 with mutant forms containing cyto-
plasmic domain deletions results in the rescue of the 
majority of defects associated with the absence of the 
 
a
 
PS2
 
 subunit, however, the mutant PS2 integrins are ex-
cessively active. Muscles containing these mutant inte-
grins make extra muscle attachments at aberrant posi-
tions on the muscle surface, disrupting the muscle 
pattern and causing embryonic lethality. A gain-
of-function phenotype is not observed in the visceral 
mesoderm, showing that regulation of integrin activity 
is tissue-specific. These results suggest that the 
 
a
 
PS2
 
 
subunit cytoplasmic domain is required for inside-out 
regulation of integrin affinity, as has been seen with the 
integrin 
 
a
 
IIb
 
b
 
3
 
.
 
C
 
hanges
 
 in cell adhesiveness in response to devel-
opmental cues are critical in cell migration and dif-
ferentiation. Cell adhesion is controlled by modu-
lating the binding properties of cell surface receptors and
their ligands. One of the first instances of this regulation
occurring in embryogenesis happens during compaction of
the early mouse embryo to form the blastocyst. The sur-
face expression of the cell adhesion molecule E-cadherin
does not change, but instead is activated at the eight-cell
stage by intracellular events (Fleming and Johnson, 1988).
Another family of cell adhesion receptors that undergoes
modulation of activity is the integrins, which play a major
role in cell–cell contact and in interactions between cells
and the extracellular matrix (Hynes, 1992). In a number of
cases it has been shown that integrin affinity for extracel-
lular ligands is modulated by an intracellular mechanism
(inside-out signaling), and that this modulation is corre-
lated with changes in cellular behavior. During blood clot-
ting, platelet binding to fibrinogen is achieved by activat-
ing the 
 
a
 
IIb
 
b
 
3
 
 integrin, which is already present on the cell
surface in an inactive form (Manning and Brass, 1991;
Shattil and Brugge, 1991). The 
 
b
 
2
 
 integrins expressed on
leukocytes undergo activation in a similar way to that oc-
curring in 
 
a
 
IIb
 
b
 
3
 
 integrins (Arnaout, 1990; Larson and
Springer, 1990). At sites of inflammation, the 
 
b
 
2
 
 integrins,
which are in an inactive state on circulating leukocytes, are
exposed to and activated by inflammatory mediators dur-
ing rolling, a low-affinity adhesion step mediated by selec-
tins. An analogous situation exists for T lymphocytes,
where cross-linking of CD3 or the costimulating receptor
CD2 leads to activation of 
 
a
 
L
 
b
 
2
 
 integrin on the T cells (van
Kooyk et al., 1989). In both cases, activation of integrins is
mediated by an adhesion and intracellular signaling cas-
cade that involves protein kinase C (Butcher, 1991; Dustin
and Springer, 1991). Modulation of 
 
b
 
1
 
 integrin activity has
also been found to occur during the final stage of terminal
differentiation in keratinocytes. In this case, keratinocyte
detachment from the basement membrane correlates with
loss in the ability of the 
 
b
 
1
 
 integrins to bind ligands, re-
duced transport of newly synthesized subunits to the cell
surface, and loss of mature integrins from the cell surface
(Adams and Watt, 1990; Hotchin and Watt, 1992; Hotchin
et al., 1995).
It seems vital to ensure that integrins are only activated
at the right times and places. For example, inappropriate
activation of 
 
a
 
IIb
 
b
 
3
 
 integrin on resting circulatory platelets
may lead to thrombosis (Kieffer and Phillips, 1990; Kieffer
et al., 1991), and activation of the 
 
b
 
2
 
 integrins at the wrong
places on leukocytes may lead to inflammation (Arnaout,
1990; Larson and Springer, 1990). To confirm this hypoth-
esis, it is important to test these models in vivo.
Integrins cytoplasmic domains are likely targets of cyto-
plasmic signals that alter integrin affinity (reviewed in Sas-
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try and Horwitz, 1993). Requirements for 
 
b
 
 intracellular
domain function have been demonstrated for cell adhe-
sion (Hayashi et al., 1990; Hibbs et al., 1991), cell spread-
ing (Ylanne et al., 1993), and adhesion-dependent phos-
phorylation of pp125 focal adhesion kinase (Guan et al.,
1991; Hanks et al., 1992). A variety of experiments in cell
culture have shown that the 
 
a
 
 cytoplasmic domains of in-
tegrins also play critical roles in determining adhesive ac-
tivity. However, the results are somehow contradictory. It
has been shown that deletion of the 
 
a
 
2
 
, 
 
a
 
4
 
, or 
 
a
 
6
 
 tails after
the highly conserved 
 
a
 
 subunit membrane proximal motif
GFFKR leads to a loss of adhesive activity (Kassner and
Hemler, 1993; Kawaguchi and Hemler, 1993; Shaw and
Mercurio, 1993; Kassner et al., 1994). Conversely, deletion
of the 
 
a
 
L
 
, 
 
a
 
1
 
,
 
 
 
or 
 
a
 
5 
 
cytoplasmic domains does not affect the
ability of the mutant 
 
a
 
L
 
b
 
2
 
, 
 
a
 
1
 
b
 
1
 
,
 
 
 
or 
 
a
 
5
 
b
 
1 
 
receptors to medi-
ate adhesion to their respective ligands (Hibbs et al., 1991;
Bauer et al., 1993; Briesewitz et al., 1993). In addition, in
the only system where mutations in integrin subunits have
been tested for their effect on inside-out signaling, truncat-
ing the 
 
a
 
IIb
 
 cytoplasmic domain mimics inside-out activa-
tion and results in an integrin that constitutively binds its
ligand fibrinogen (O’Toole et al., 1991). A mutation that
just deletes the 
 
a
 
 cytoplasmic GFFKR motif also results in
a constitutively high-affinity 
 
a
 
IIb
 
b
 
3
 
 integrin (O’Toole et al.,
1994). Therefore, inside-out signaling appears to occur by
modulating the 
 
a
 
 cytoplasmic tail, since deleting it mim-
icks inside-out activation. We were interested in determin-
ing whether the cytoplasmic domains of integrin 
 
a
 
 sub-
units are required for regulation of integrin activity during
embryogenesis. In 
 
Xenopus
 
, changes in cellular adhesion
to fibronectin are correlated with increased migration of
cells during gastrulation, suggesting that inside-out inte-
grin modulation may play an important role in this devel-
opmental event (Ramos et al., 1996). We wished to test
whether the ability of integrins to be modulated by intra-
cellular interactions with the 
 
a
 
 subunit is not only corre-
lated with morphogenetic events, but is essential for them
to occur.
Identification and characterization of the 
 
Drosophila
 
position-specific (PS)
 
1
 
 integrins provides the opportunity
to examine integrin function in the developing organism.
The two PS integrins, PS1 and PS2, share a common 
 
b
 
 sub-
unit (
 
b
 
PS
 
), but have different 
 
a
 
 subunits (
 
a
 
PS1
 
 and 
 
a
 
PS2
 
).
The 
 
Drosophila
 
 PS integrins have amino acid sequence
homology with vertebrate integrins, and structural and
functional features of the vertebrate integrins are con-
served in the fly proteins (Bogaert et al., 1987; MacKrell et
al., 1988; Hirano et al., 1991; Bunch and Brower, 1992;
Wehrli et al., 1993). Throughout development, the two PS
integrins are expressed in complementary but closely asso-
ciated tissues. For example, high levels of PS integrins are
found at sites where the muscles attach to the epidermis,
with 
 
a
 
PS1
 
b
 
PS
 
 (PS1) restricted to the epidermal cells, and
 
a
 
PS2
 
b
 
PS
 
 (PS2) to the muscle cells (Bogaert et al., 1987;
Leptin et al., 1989; Wehrli et al., 1993). An analogous situ-
ation occurs in the midgut, with PS1 expressed in the gut
endothelium and PS2 in the visceral mesoderm that sur-
rounds the gut (Bogaert et al., 1987; Leptin et al., 1989).
Loss of function mutations in 
 
inflated
 
 (
 
if
 
; 
 
a
 
PS2
 
 subunit
gene) have demonstrated that the PS2 integrin is required
in formation and maintenance of somatic muscle attach-
ments to the epidermis, and the attachment of the visceral
muscles to the midgut epithelium (Babrant and Brower,
1993; Brown, 1994; Prokop et al., 1998).
Although the roles of PS integrins during embryonic de-
velopment have been intensively studied, we do not know
if their function is regulated during development. It has
been shown that the cytoplasmic domain of the 
 
b
 
PS 
 
inte-
grin subunit is essential during development for 
 
b
 
PS
 
 func-
tions (Grinblat et al., 1994). Futhermore, we have shown
that this domain is sufficient to localize a chimeric protein
to the end of the muscles, demonstrating the existence of
an inside-out mechanism able to localize the PS2 integrin
(Martin-Bermudo and Brown, 1996). In this work we test
whether this or other inside-out signaling processes are
used to modulate PS2 integrin activity. Since a deletion of
the 
 
a
 
 cytoplasmic domain has generated a constitutively
active 
 
a
 
IIb
 
b
 
3
 
 integrin (O’Toole et al., 1994), we tested
whether a similar mutation in the 
 
a
 
 subunit of the PS2 in-
tegrin would cause developmental defects, indicating that
modulation of integrin activity is essential for embryonic
development. We show that deletion of the 
 
a
 
PS2 
 
cytoplas-
mic domain leads to formation of a PS2 integrin that medi-
ates formation of an abnormal number and size of muscle
attachments consistent with PS2 being constitutively acti-
vated. This result demonstrates that modulation of integrin
function through the cytoplasmic domain of the 
 
a
 
 subunit
is essential for embryonic morphogenesis.
 
Materials and Methods
 
Preparation of Mutant Integrins
 
The UAS-
 
a
 
PS2
 
 cytoplasmic tail mutants were generated by site-directed
mutagenesis using the technique described by Picard et al. (1994). The two
mutations were made by: (a) inserting a stop codon at the end of exon 11
so a truncated form of the protein would be produced (
 
D
 
cyt); and (b) de-
leting the highly conserved GFFNR motif (
 
D
 
GFFNR). To make the 
 
D
 
cyt
mutant, we amplified a portion of the 
 
a
 
PS2
 
 gene from a subclone of 
 
a
 
PS2
 
encoding the COOH end (part of exon 11 and 12) using the PCR. For this
amplification we used three primers: two flanking primers (vector se-
quence) that were upstream (P1) and downstream (P2) of the mutation
site, and a mutant primer that introduced a stop codon at the end of exon
11 (5
 
9
 
GG CTG CTC TAC AAG TAG GAT CCT TAA CCC TTT CTC
TCG G 3
 
9
 
). The mutant primer and P2 were used to produce a mega
primer, which was then used in conjunction with P1 to produce the desired
fragment. This PCR fragment was digested with BglII and SalI, gel-puri-
fied, subcloned, and checked by sequencing. This fragment was then used
to replace the corresponding fragment in the wild-type UAS-
 
a
 
PS2c/g
 
 con-
struct (Martin-Bermudo et al., 1997). To obtain the 
 
D
 
GFFNR construct,
the same procedure was followed as for 
 
D
 
cyt, but in this case the mutant
primer was missing the bases encoding the GFFNR motif at the start of
exon 12 (5
 
9
 
 CCT TTA ACC CTA CAG TGC AAC CGG CCA ACG
GAT CAC TCG C 3
 
9
 
). To generate germline transformants, both con-
structs were injected into flies using standard methods.
The construction of the minigene has been described (Bloor and
Brown, 1998). To generate the 
 
D
 
GFFNR mutant form of this minigene,
we replaced a SacII-RsrII fragment in the wild-type minigene with that
from the UAS-
 
a
 
PS2
 
D
 
GFFNR.
 
Drosophila Strains
 
The integrin mutant allele used in this study is the null allele 
 
if
 
B4 
 
(Brown,
1994) marked with 
 
y w f
 
. Since 
 
if
 
 is on the X chromosome, to select the
mutant embryos we have used two derivatives of the 
 
FM6
 
 balancer—a 
 
y
 
1
 
derivative and a 
 
lacZ
 
 marked derivative—and they have been used as de-
 
1. 
 
Abbreviation used in this manuscript
 
: PS, position-specific. 
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scribed in Martin-Bermudo et al., (1997). To assay rescue of 
 
inflated
 
 em-
bryonic lethality, a 4-h collection of embryos at 28
 
8
 
C was transferred to
new apple juice plates in groups of 20 aged for 24 h, and the embryos that
failed to hatch were counted. In these experiments, we distinguished the
mutant embryos with the 
 
y
 
 marker. We have used the following indepen-
dent inserts for the different constructs: UAS-
 
a
 
PS2c/g
 
: 3.A (Martin-Ber-
mudo et al., 1997); UAS-
 
a
 
PS2
 
D
 
cyt
 
: 1, 2, 6; UAS-
 
a
 
PS2
 
D
 
GFFNR
 
: 4, 6; minigene-
 
a
 
PS
 
2
 
: 47, 55; and minigene-
 
a
 
PS
 
2DGFFNR: 76, 96.
Histology
Whole mount staining of embryos was performed using standard proce-
dures. The primary antibodies used were the CF6G11 mouse mAb against
bPS (1:1,000; Brower et al., 1984), the 7A10 PS2 hc/2 rat mAb against aPS2
(1:5; Bogaert, et al., 1987), anti-muscle myosin (Kiehart and Feghali,
1986), a mouse anti-gp150 (Fashena and Zinn, 1997), and anti-b-galactosi-
dase (Cappel Laboratories, Malvern, PA). We used a biotin-labeled sec-
ondary antibody followed by the Vectastain Elite ABC Kit (Vector Labs,
Inc., Burlingame, CA) enhancement to stain the embryos. To visualize the
visceral mesoderm, dissected guts were fixed in 5% formaldehyde in PBT
for 20 min and stained with rhodamine-labeled phalloidin as described in
Xue and Cooley (1993). Images were obtained by photography on a Zeiss
Axiophot followed by scanning with a Nikon Coolscan (Nikon Inc., In-
strument Group, Melville, NY), or directly from the MRC1000 Confo-
cal™ microscope (Bio-Rad Laboratories, Hercules, CA). Images were as-
sembled in Photoshop 3.0 (Adobe Systems, Inc., Mountain View, CA)
and labeled in Freehand 5.5™ (Macromedia, San Francisco, CA).
Results
Expression of a PS2 Integrin with
Deletions Within the a Cytoplasmic Domain in the 
Developing Embryo
Two mutant aPS2 subunit genes containing deletions within
the cytoplasmic domain were constructed (Fig. 1). In one
construct, we have deleted the entire cytoplasmic domain
(aPS2Dcyt), and in the other we removed the aPS2 variant
form of the highly conserved domain GFFKR (aPS2DGFFNR;
see Materials and Methods). We have already successfully
used the GAL4 system (Brand and Perrimon, 1993) to res-
cue the embryonic lethality of inflated mutant embryos
that lack the aPS2 subunit by expressing a wild-type aPS2
construct in the mesoderm using a combination of two
GAL4 lines: twist-GAL4 and 24B (Martin-Bermudo et al.,
1997). We have previously shown that in inflated mutant
embryos, the bPS subunit is not found at the end of mus-
cles, but remains within the endoplasmic reticulum (Mar-
tin-Bermudo et al., 1997; and Fig. 2 b). We have also
shown that we can restore wild-type levels of bPS localiza-
tion to the ends of muscles in mutant embryos by express-
ing the aPS2 subunit with the GAL4 system. To analyze the
role of the cytoplasmic domain of the aPS2 subunit in regu-
lating PS2 integrin function during embryogenesis, we
have used the same GAL4 lines—twist-GAL4 and 24B—
to express the truncated forms of the aPS2 subunit in the
mesoderm of inflated mutant embryos. To examine
whether the mutant aPS2 subunits are able to form het-
erodimers with the bPS that are properly localized, we
stained the different transgenic embryos with an anti-bPS
antibody. When we express either of the two truncated
forms of the a subunit in these mutant embryos, we find
that they can also restore bPS localization (Fig. 2 c and data
not shown). From these results we conclude that aPS2 sub-
units containing deletions in the cytoplasmic domain are
able to form heterodimers with the bPS subunit that are
properly localized to the ends of the muscles. We then
tested whether these mutant integrin heterodimers are
able to function in the developing embryo.
Regulation of PS2 Integrin Activity
Through the a Subunit Cytoplasmic Domain 
is Essential for Normal Morphogenesis
Experiments with cells in culture have shown that integrin
a cytoplasmic domains can regulate the ligand-binding
function of their extracellular domains (reviewed in Gins-
berg, et al., 1992; Hynes, 1992); however, the results ob-
tained vary depending on the integrin examined. As men-
tioned in the introduction, deletion of a cytoplasmic
domains can have three different effects on the adhesive
activity of the integrin: to alter it, abolish it, or constitu-
tively active it. Therefore, it was not simple to predict the
consequences that mutating the cytoplasmic domain of the
aPS2 subunit would have on embryonic development.
Expression of the aPS2DGFFNR mutant subunit in embryos
that lack aPS2 rescues the ifB4 embryonic lethality almost as
well as the wild-type construct (Fig. 3; Martin-Bermudo et al.,
1997). However, if we express the aPS2Dcyt mutant form, we
find that it is unable to rescue the lethality caused by the
absence of aPS2 (Fig. 3). This result is not due to lower lev-
els of expression of this mutant integrin, since using two
copies of the UAS-aPS2Dcyt transgene does not significantly
improve the ability of this mutant form to rescue ifB4 (Fig.
3). The failure of the Dcyt truncated form of the aPS2 sub-
unit to rescue the inflated embryonic lethality could be due
to the fact that deletion of the cytoplasmic domain creates
a nonfunctional aPS2 subunit. Alternatively, this deletion
could create a constitutively active receptor, which causes
the lethal phenotype. To distinguish between these two
possibilities, we examined the muscle attachment pheno-
type of embryos in which the wild-type aPS2 subunit has
been replaced with the truncated forms of the aPS2 subunit.
In a wild-type Drosophila embryo, mononucleated myo-
blasts fuse to form myotubes, and during this process they
elongate and attach to specific sites on the basal surface of
the epidermis (apodemes). Initially, one pole of the mus-
Figure 1. Amino acid sequence
of the two mutated aPS2 cyto-
plasmic domains. The cyto-
plasmic tail and part of the
transmembrane region of aPS2
subunit are shown at the top.
Beneath this, the two mutants
generated are shown: aPS2Dcyt
and aPS2DGFFNR.The Journal of Cell Biology, Volume 141, 1998 1076
cle is attached to the epidermis at one apodeme, and the
other consists of a growth cone–like structure that mi-
grates towards the other apodeme (Bate, 1990). Addi-
tional membrane projections are also observed on the lat-
eral surfaces of the muscles, but these decrease as the
growth cone is established. By the end of stage 15, approx-
imately half way through embryogenesis, most of the mus-
cles have reached their mature size, their surfaces no
longer show any membrane projections, and both ends are
stably associated with their respective apodemes. In em-
bryos mutant for the PS2 integrin, the muscles then begin
to detach from the apodemes, showing that the PS2 inte-
grin is essential for formation of strong muscle attach-
ments, but not for their initial formation (Wright, 1960;
Brown, 1994).
To look at the ability of the truncated forms of the aPS2
subunit to rescue this muscle detachment phenotype, we
have stained if mutant embryos carrying the different
transgenes with an anti-muscle myosin antibody (Fig. 4).
In the absence of any UAS construct, the if mutant em-
bryos show a muscle detachment phenotype, as expected
(Fig. 4 b). The expression of a wild-type UAS-aPS2 con-
struct completely rescues the muscle phenotype (Martin-
Bermudo et al., 1997). if mutant embryos carrying the
UAS-aPS2DGFFNR construct are almost completely rescued,
but they have a very mild muscle detachment phenotype,
with just one muscle detached in 15% of the mutant em-
bryos (not shown). In contrast, we could not detect any
muscle detachment phenotype in those if mutant embryos
carrying the UAS-aPS2Dcyt construct (Fig. 4 c), despite the
failure of this construct to rescue embryonic lethality.
Closer examination revealed that both mutant forms of
the aPS2 subunit cause two new phenotypes. First, the mus-
cles make attachments that are larger than in wild-type
embryos, as can be seen particularly clearly for the trans-
verse muscles, which have broader tips (compare enlarge-
ments in Fig. 4, a and c). Second, the muscles of these em-
bryos form abnormal attachments along the lateral
surfaces. For example, the wild-type ventral longitudinal
muscles (VL) normally extend the whole length of each
segment and attach to apodemes at the segment boundary,
while ventral longitudinal muscles containing the mutant
PS2 integrins make new attachments to the ventral acute
muscles (VA) in the middle of the segment (arrowheads in
Fig. 4, d and e). Another aspect of this phenotype is the
aberrant processes that are found extending from the lat-
eral surfaces of the VL towards the lateral transverse mus-
cles (LT), as seen with an antibody against the transmem-
brane glycoprotein gp150 (Fashena and Zinn, 1997) that
stains the surface of muscles (Fig. 5). The mutant
aPS2DcytbPS integrin is found at the ectopic attachment sites
(Fig. 4 d), and the extracellular matrix protein Tiggrin
(Fogerty et al., 1994), a PS2 ligand, is also recruited (Fig. 4 e).
Although staining of both PS2 and Tiggrin at the ectopic
site appears modest, it is the amount expected for the end
of a single muscle, compared with the segment border
Figure 2. The aPS2 cytoplasmic
domain is not required for lo-
calization of the PS2 integrin
to the end of the muscles. An
antibody against the bPS sub-
unit was used to visualize ex-
pression of the PS2 integrin.
(a) In a wild-type embryo, the
PS2 integrin is localized at the
muscle attachment sites (m.a.).
(b) In mutant embryos that
lack the aPS2 subunit, the bPS
staining at the end of the mus-
cles is lost. (c) Expression of
the UAS-aPS2Dcyt construct in
an aPS2 mutant embryo produces a mutant heterodimer that is
correctly localized at the muscle termini.
Figure 3. The ability of differ-
ent combinations of the UAS-
aPS2 cytoplasmic mutants
(driven by twist-GAL4 and
24B) to rescue the aPS2 embry-
onic lethality is indicated by
the black bars. The percent
rescue of aPS2 embryonic le-
thality was calculated as fol-
lowing: (1/4 total number of
embryos  2  unhatched em-
bryos)/ 1/4 total number of
embryos 3 100). The total
number of embryos counted is
shown on the left side of each
bar. The embryonic lethality of
aPS2  mutants can be rescued
with either the UAS-aPS2 (com-
pletely) or the UAS-aPS2DGFFNR (nearly completely) constructs. In contrast, the UAS-aPS2Dcyt construct is unable to rescue the lethality.
A subset of embryos containing 50% mutant and 50% wild-type embryos was selected using a marked balancer chromosome (the num-
ber is indicated to the left side of each grey bar). This subset was examined by staining the muscles for muscle myosin (see Fig. 4), and
was scored for a loss of function (muscle detachment, light grey bars) or gain of function (formation of ectopic attachment sites, dark
grey bars) phenotypes. The percent of embryos with muscle phenotype was calculated as follows: (number of embryos with muscle phe-
notype)/ 1/2 number of selected embryos 3 100). Deletion of the cytoplasmic tail, and to a lesser extent deletion of the GFFNR motif,
causes gain-of-function phenotypes.Martin-Bermudo et al. Regulation of Integrin Function in the Embryo 1077
where many muscles attach (three layers from external to
internal). These phenotypes are never observed in if mu-
tant embryos carrying the wild-type UAS-aPS2 transgene.
The fraction of embryos that have broader tips and ec-
topic attachment sites varies with the different constructs
(Fig. 3). Using one copy of the UAS-aPS2Dcyt construct, we
find that z20% of the mutant embryos have both pheno-
types (Fig. 3), and two copies increase the fraction to 38%
(Fig. 3). Enlargement of the tips of the transverse muscles
occurs in all of the segments analyzed (T2–A8). Ectopic
attachments or abnormal processes are found in 3.8 seg-
ments per embryo on average (from 27 embryos with a
phenotype), usually in segments A2–A5. As mentioned
before, the UAS-aPS2DGFFNR construct is also able to gener-
ate these phenotypes, although less frequently, with only
10% of the embryos having these phenotypes when a sin-
gle copy of the construct is expressed in them, which in-
creases to 18% when using two copies (Fig. 3). Ectopic
attachments or abnormal processes are found in 1.7 seg-
ments per embryo (from 31 embryos with a phenotype),
while broadening of the tips of the transverse muscles is
found in all segments examined.
In summary, PS2 integrins containing mutant a subunit
cytoplasmic domains are able to mediate adhesion of the
embryonic muscles. However, deletion of the cytoplasmic
domain, and to a lesser degree the GFFNR motif, causes
enhanced adhesive activity such that the extent of the
muscle surface that forms an attachment is increased, and
abnormal attachments are formed along the lateral sur-
faces of the muscles. When the entire cytoplasmic domain
is deleted, excessive adhesion by the muscles is so exten-
sive that it causes embryonic lethality. These results sug-
gest that there is a mechanism that normally limits PS2 in-
tegrin adhesion to the discrete regions at the ends of the
muscles, acting on the cytoplasmic domain of the aPS2 sub-
unit. One way this mechanism could be achieved is by in-
side-out activation of PS2 integrin affinity only at the mus-
cle termini. Excessive adhesion of the muscles is consistent
with the possibility that the aPS2 subunit cytoplasmic do-
main deletions cause constitutive activation of the PS2 in-
tegrin, converting the integrin to a high-affinity form, as
has been shown for the integrin aIIbb3 (O’Toole et al.,
1994).
Neither of the new phenotypes, larger or ectopic muscle
attachments, are observed when we express the mutant
transgenes in a wild-type genetic background, demonstrat-
ing that this phenotype is only caused in the absence of the
endogenous aPS2 gene. This observation suggests that if the
wild-type  aPS2 subunit is available, the bPS subunit will
form heterodimers with it in preference to the aPS2 sub-
units that have mutant or absent cytoplasmic tails, even
when the mutant forms are overexpressed (see below).
This suggestion may explain why increasing the number of
copies of the UAS-mutant aPS2 construct increases the fre-
quency of the phenotype, even when a single copy appears
to produce excess aPS2 protein. Therefore, heterodimer
formation may be normally initiated by interactions be-
tween the cytoplasmic domains, as suggested by previous
work (Briesewitz et al., 1995).
The other possible explanation of these results is that
excessive muscle adhesion only occurs when all the PS2 in-
tegrins on the surface are mutants. This explanation sug-
gests a model where wild-type integrin can send signals to
downregulate adhesion from the lateral surfaces.
Different Requirements for Inside-out PS2 Signaling in 
Different Embryonic Tissues
We next tested the requirements for the a cytoplasmic do-
main in another main site of PS2 integrin function: gut de-
velopment. We have examined the midgut, the associated
gastric caeca, and the proventriculus, which is part of the
Figure 4. The cytoplasmic domain of the aPS2 subunit is required
for normal pattern of muscle attachments. Embryos in a–c are
stained with an antibody for muscle myosin to reveal the pattern
of the muscles. In embryos that lack the aPS2 subunit, the muscles
detach (arrow; b) compared with wild-type (a). Expression of
aPS2Dcyt in the muscles of mutant embryos rescues the muscle de-
tachment phenotype (c). However, the transverse muscles look
broader at their tips (see inset in c and compare with inset in a),
and in 37% of the mutant embryos (Fig. 3) the ventral lateral
muscle (VL) form ectopic muscle attachments with the ventral
acute muscles (VA; shown in c, and in higher magnification in d
and e). These new attachment sites contain the mutant PS2 inte-
grin (d; revealed with an antibody against bPS) and the extracellu-
lar PS2 ligand, Tiggrin (e). d and e show one segment with the
segment borders marked by arrows.
Figure 5. The cytoplasmic domain of the aPS2 subunit is required
to prevent ectopic processes from the lateral surfaces of the mus-
cles. An antibody against the transmembrane protein gp150 has
been used to show the muscle surface. a and b show the outline of
the muscles of a wild-type embryo at two different magnifica-
tions. The higher magnification panel shows that wild-type mus-
cles at stage 16 have smooth lateral surfaces. In contrast, muscles
that express aPS2Dcyt (c and d) have processes emerging from their
lateral surface. d shows how ventral (VL) and longitudinal (LT)
muscles in mutant embryos with aPS2Dcyt send out growth cone–
like processes to each other (black arrow).The Journal of Cell Biology, Volume 141, 1998 1078
foregut. There are several phenotypes in these tissues as-
sociated with the loss of the PS2 integrin: (a) morphogene-
sis of the gastric caeca does not progress normally, with
only two blunt gastric caeca being formed instead of the
four long gastric caeca formed in a wild-type larvae (see
Fig. 7 and Martin-Bermudo et al., 1997); (b) the midgut
does not elongate properly (Figs. 6 and 7); and (c) the con-
tinuity of the visceral mesoderm layer surrounding the gut
is disrupted, as seen by phalloidin staining of filamentous
actin in the visceral muscles (Fig. 6). Development of the
proventriculus is normal until late stage 16 in the absence
of the aPS2 integrin subunit (Pankratz and Hoch, 1995), but
we have found defects later in embryogenesis (Fig. 7): the
keyhole region of the esophagus migrates inwards to form
the inner layer of the esophagus, but becomes pulled out
in PS2 mutant guts (Fig. 7, a and b; arrowheads; Pankratz
and Hoch, 1995). This, like the muscle attachments, is an
adhesion defect, since the structure initially forms nor-
mally (Pankratz and Hoch, 1995). When we express either
of the two truncated forms of the aPS2 subunit, we observe
a complete rescue of the morphogenesis of the gastric
caeca and elongation of the midgut (Fig. 6 and 7), as we
have seen with the wild-type subunit (Martin-Bermudo
et al., 1997). In addition, the visceral mesoderm phenotype
is almost completely rescued. It is only at late stage 17 that
the visceral mesoderm becomes mildly disrupted at only
one position along the gut of embryos carrying the aPS2
subunit mutant forms (Fig. 6). Both mutant PS2 integrins
fail to rescue the proventriculus phenotype (Fig. 7). Since
these phenotypes occur at the very end of embryogenesis,
they could be due to the reduced stability of the truncated
forms of the aPS2 subunit, or to the fact that the GAL4
drivers that we have used do not result in wild-type levels
of PS2 integrin expression in these particular tissues, even
though the wild-type UAS-aPS2 is able to rescue these phe-
notypes completely. This latter explanation is reinforced
by the fact that genetically defined weak (hypomorphic)
mutations in the aPS2 subunit show identical phenotypes
(Bloor and Brown, 1998, and our unpublished observa-
tions). We have not observed any gain of function pheno-
types in the developing gut.
Does the GFFNR Motif of the aPS2
Cytoplasmic Tail Play a Role in Synthesis or Stability
of the PS2 Integrin?
In some cases the cytoplasmic tail of the a subunit is essen-
tial for effective translation or surface expression of the in-
tegrin heterodimer (e.g., Bauer et al., 1993). Our results in
the Drosophila embryo using the GAL4 system show that
deletions within the aPS2 cytoplasmic domain do not pre-
vent surface expression of the PS2 heterodimer. However,
using the GAL4 system leads to much higher levels of ex-
pression of the aPS2 subunits compared with the endoge-
nous level of PS2 integrin expression (Fig. 8 b), and the
excess remains in the endoplasmic reticulum. This overex-
pression could mask any requirement of the cytoplasmic
domain in making a stable PS2 integrin at the end of the
muscles. In fact, despite this overexpression there appears
to be less PS2 heterodimer at the end of the muscles, with
GAL4-expressed mutants compared with the GAL4-
expressed wild-type aPS2 subunit, judging by the staining
Figure 6. The aPS2 cytoplasmic domain is not essential for PS2 in-
tegrin function in the visceral mesoderm. Dissected guts stained
for actin with phalloidin conjugated to rhodamine show the vis-
ceral mesoderm surrounding the gut. The gut musculature is se-
verely disrupted in animals that lack the aPS2 subunit (b) in con-
trast to the visceral mesoderm surrounding the gut in wild-type
individuals (a). In aPS2 mutants that carry either the aPS2DGFFNR
construct (c) or the aPS2Dcyt construct (d), the visceral mesoderm
phenotype is almost completely rescued, with only a mild detach-
ment around the proventriculus remaining.
Figure 7. The aPS2 cytoplasmic domain is required for PS2 inte-
grin function in the proventriculus, but is not required for mor-
phogenesis of the gastric caeca. At this stage, a wild-type proven-
triculus is a three-layered valvelike structure at the junction with
the midgut. Four long, thin gastric caeca (three of them are
marked with dots, and the remaining one is out of the plane of fo-
cus) are formed (a). Embryos lacking the aPS2 subunit show an
abnormal proventriculus in which the inner layer has been pulled
out, and only two blunt gastric caeca are seen (dots; b). Both phe-
notypes are fully rescued by a GAL4-driven wild-type aPS2 con-
struct (not shown), but only the gastric caeca, and not the proven-
triculus, are rescued by aPS2DGFFNR or aPS2Dcyt.Martin-Bermudo et al. Regulation of Integrin Function in the Embryo 1079
with an antibody against the b subunit (Fig. 1 and data not
shown), although this is hard to quantify. Therefore, to
clarify whether deletion of the GFFNR within the cyto-
plasmic domain affects the ability of the aPS2 subunit to
form a stable heterodimer with the bPS subunit, we con-
structed a gene that will express aPS2DGFFNR at levels simi-
lar to those of the wild-type gene. To do this we used a
shortened version of aPS2 gene, a minigene containing 24 kb
of the aPS2 genomic DNA, that is able to rescue completely
the embryonic lethality of an if null mutation (Bloor and
Brown, 1998). This construct is expressed in the somatic
muscles at levels very similar to those of the wild-type aPS2
gene (Fig. 8 c). Deletion of the GFFNR motif within the a
cytoplasmic domain of this minigene leads to very low lev-
els of PS2 expression in the muscles (compare Fig. 8, d
with c and a), and it does not rescue the embryonic lethal-
ity associated with an if null mutation. Independent lines
of each construct yielded similar results, ruling out the
possibility that the difference in the levels of expression
are due to the site of insertion of the transgenes. From
these results we conclude that the highly conserved
GFFNR motif is indeed required for effective synthesis,
assembly, and/or stability of the PS2 integrin at the muscle
attachment sites.
Discussion
In this work we have examined the requirements for the
integrin aPS2 subunit cytoplasmic domain in modulating in-
tegrin activity in the developing embryo. We have shown
that the cytoplasmic domain is not required for PS2 inte-
grin adhesion, but instead is required to prevent adhesion
at the wrong locations. In the wild-type Drosophila em-
bryo, PS2 integrin adhesion is tightly localized to specific
sites at the ends of the somatic muscles. In contrast, when
the wild-type PS2 integrin is replaced with mutant forms
of the PS2 integrin lacking portions of the cytoplasmic do-
main, then PS2 integrin–mediated adhesion is no longer
tightly localized. The muscles make ectopic attachments
and send out growth cone–like processes, not only from
the ends of the muscles, but also from their lateral sur-
faces. This indicates that we have created a PS2 integrin
that is functional around the entire surface of the muscles
rather than just at the ends. Therefore, we conclude that
the cytoplasmic domain of the aPS2 subunit is required to
keep the PS2 integrin inactive along the lateral surfaces of
the muscles. Normally this inhibition is only released at
the ends of the muscles where strong attachment is
needed.
Control of PS2 integrin adhesion at the ends of the mus-
cles is part of a multistep process that results in a precise
pattern of strong muscle–muscle and muscle–epidermal
cell adhesion. This process starts with an initial recogni-
tion/adhesion step, where the muscles make their contact
with and attach to specific epidermal cells. This first step is
independent of integrins and involves formation of short
regions of close membrane contact that are not by them-
selves strong enough to withstand the force of muscle con-
traction in the absence of integrin adhesion (Prokop et al.,
1998). The muscle–epidermis and muscle–muscle attach-
ments then differentiate by forming extensive hemiadher-
ens junctions, and strong PS integrin-dependent adhesion
develops. The data we have presented here suggests that
part of muscle attachment differentiation is activation of
PS2 integrin adhesion, specifically at the ends of the mus-
cles. This activation could be controlled by an inherent in-
tracellular polarity of the muscles that localizes a protein
to the ends of the muscles, which activates the PS2 integrin
through the cytoplasmic domain of the aPS2 subunit. How-
ever, it seems more likely that PS2 integrin adhesion
should only occur after successful attachment of the mus-
cle to the correct cell, and therefore be triggered by an ex-
tracellular signal. This mechanism would avoid the kind of
ectopic attachments that we have observed when the PS2
integrin cytoplasmic domain mutants are present in the
muscles. The extracellular signal could be transmitted by
an unknown transmembrane receptor that sends an intra-
cellular signal, acting on the aPS2 subunit cytoplasmic tail
to initiate adhesion. It is also possible that the PS2 integrin
itself transmits the signal that results in integrin activation.
The low-affinity interaction between PS2 and a localized
extracellular ligand might convert PS2 into a high-affinity
conformation that binds more strongly to a variety of ex-
tracellular ligands, including Tiggrin. A similar ligand-depen-
dent activation has been described for the aIIbb3 integrin
(Du et al., 1991). Interaction of PS2 with ligands could also
stabilize the active state at the ends of the muscles, as has
been proposed for other integrins (Keizer et al., 1988; van
Kooyk et al., 1991). If this last model is true, then deletion
of the cytoplasmic tail of the aPS2 subunit mimics an activa-
Figure 8. The GFFNR motif is required for wild-type levels of
cell surface expression of the PS2 integrin. In this case, expres-
sion of PS2 integrins has been detected using an antibody against
aPS2. Using the GAL4 system to express the aPS2DGFFNR construct
leads to an excess of aPS2. One fraction of it is localized to the at-
tachment sites (arrow), and the rest remains inside the cell. b
shows how aPS2 made by a minigene (minigenewt) is localized at
the surface of the muscles at the attachment sites (arrow) at levels
indistinguishable from the wild-type aPS2 (a). In contrast, a dele-
tion of the GFFNR motif within the minigene results in greatly
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tion that normally occurs by extracellular interaction of a
ligand with the integrin.
Our experiments have not determined the mechanistic
basis of the activation that occurs when the aPS2 cytoplas-
mic tail is deleted. If the PS2 integrin behaves like the
platelet integrin aIIbb3, then activation occurs by a confor-
mational change in the protein that increases the affinity of
the integrin for its ligands, which may be combined with an
increase in avidity promoted by clustering of the integrin.
As the cytoplasmic domain mutants of the PS2 integrin are
expressed at modestly lower levels than the wild-type PS2
integrin, it seems unlikely that the gain-of-function pheno-
types are caused by the mutations, leading to excessive
quantities of the integrin, or one that turns over less rap-
idly. Indeed, the gain-of-function phenotypes do not occur
when the PS2 heterodimer is overexpressed by GAL4,
driving expression of both UAS-aPS2 and UAS-bPS constructs
(our unpublished observations). In addition, the process of
muscle attachment occurs very rapidly (within 4 h), mak-
ing changes in the rate of turnover or assembly less likely
to contribute to the gain-of-function phenotypes. It is
therefore tempting to speculate that, similar to the integrin
aIIbb3, the affinity of PS2 integrin for extracellular ligands
is modulated by the aPS2 cytoplasmic domain.
We have also analyzed the effect that deletions within
the cytoplasmic tail of the aPS2 subunit have on the func-
tion of the PS2 integrin in other tissues. In general, the
mutant PS2 integrins can replace the wild-type PS2 inte-
grin in the visceral mesoderm and promote normal mor-
phogenesis of the midgut. We have not detected any gain-
of-function phenotypes that would indicate that control of
the activation state of the PS2 integrin in the visceral me-
soderm is as vital as it is in the somatic muscles. This result
demonstrates that the different embryonic tissues have
different requirements for the aPS2 subunit cytoplasmic
domain, consistent with previous studies showing that dif-
ferent cell types have different ways of regulating integrin
activity. If information processing by the signaling machin-
ery of a cell is dependent on cell type, then one conse-
quence might be for one cell type to possess integrins in a
higher activation state than other types. Therefore, there
are two possible ways to explain how the aPS2 cytoplasmic
domain can contribute in different ways to PS2 function:
(a) there could be tissues in which the PS2 integrin is re-
quired to be active all the time, as in the visceral meso-
derm, while in other tissues like the somatic muscles its ac-
tivity needs to be regulated. This difference may reflect
the importance for the large multinucleate somatic mus-
cles to have discrete sites of integrin adhesion, while the
visceral muscles may have more uniform adhesion along
the cell surface. (b) the PS2 integrin might perform differ-
ent functions in the different tissues (e.g. mediating adhe-
sion, migration, or differentiation), and the aPS2 cytoplas-
mic tail might not be essential for all of these cellular
functions. This latter hypothesis is consistent with data
showing that deletion of the a5 cytoplasmic domain of the
a5b1 integrin still permits efficient adhesion and increases
in tyrosine phosphorylation, but causes reduced motility
and cell spreading (Bauer et al., 1993). Identification of
proteins that interact with the a subunit cytoplasmic do-
mains will provide insight into the mechanisms of this reg-
ulation.
Finally, our results have shown that deletion of the en-
tire cytoplasmic domain has a stronger effect than deletion
of the highly conserved motif GFFNR, suggesting that
there must be other regions within the aPS2 cytoplasmic
domain that contribute to PS2 integrin function regula-
tion. A more detailed analysis of small deletions within the
cytoplasmic domain will help to identify the different re-
gions involved in regulating PS2 integrin function.
In summary, our results show that during embryogenesis
it is essential to have a mechanism to regulate integrin
function at the right places. We have found that being able
to keep integrin adhesion off at the right moment and
place is just as important as having active integrins. We
also show that a mechanism to regulate integrin activity
exists in the embryo, and that activation of the integrin by
this mechanism can be mimicked by deletion of the aPS2
subunit cytoplasmic tail, suggesting that the mechanism
acts on this domain. A further characterization of this
mechanism will allow us to test whether it is only required
in some tissues during embryogenesis, or whether a similar
mechanism is used in different tissues.
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